NCT04217512View on ClinicalTrials.gov

Pantoprazole in Cisplatin Nephrotoxicity

PHASE3RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

December 1, 2030

Study Completion Date

December 30, 2030

Conditions

Oncology

Interventions

DRUG

Pantoprazole low dose

Pantoprazole 0.6 mg/kg

DRUG

Pantoprazole high dose

Pantoprazole 1.6 mg\\kg

OTHER

Standard hydration

Standard hydration alone

DRUG

Cisplatin

Cisplatin

Trial Locations (1)

Unknown

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors

lead

Sherief Abd-Elsalam

OTHER